My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 108

    1.

    Transient antiretroviral therapy selecting for common HIV-1 mutations substantially accelerates the appearance of rare mutations.

    Shiri T, Welte A.

    Theor Biol Med Model. 2008 Nov 14;5:25.PMID: 19014593 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.

    Westreich D, Eron J, Behets F, Horst C, Van Rie A.

    J Infect Dis. 2007 Mar 15;195(6):837-46. Epub 2007 Feb 7.PMID: 17299714 [PubMed - indexed for MEDLINE]Related articles

    3.

    Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission.

    Lehman DA, Chung MH, Mabuka JM, John-Stewart GC, Kiarie J, Kinuthia J, Overbaugh J.

    J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):522-9.PMID: 19502990 [PubMed - indexed for MEDLINE]Related articles

    4.

    Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.

    Moorthy A, Gupta A, Bhosale R, Tripathy S, Sastry J, Kulkarni S, Thakar M, Bharadwaj R, Kagal A, Bhore AV, Patil S, Kulkarni V, Venkataramani V, Balasubramaniam U, Suryavanshi N, Ziemniak C, Gupte N, Bollinger R, Persaud D.

    PLoS One. 2009;4(1):e4096. Epub 2009 Jan 1.PMID: 19119321 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapine.

    Basson AE, Ntsala M, Martinson N, Tlale E, Corrigan GE, Shao X, Gray G, McIntyre J, Puren A, Morris L.

    J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):538-43.PMID: 18989222 [PubMed - indexed for MEDLINE]Related articles

    6.

    Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.

    Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock PA, Asavapiriyanont S, Teeraratkul A, McConnell MS, McNicholl JM, Tappero JW.

    Clin Infect Dis. 2009 Jul 15;49(2):299-305.PMID: 19522656 [PubMed - indexed for MEDLINE]Related articles

    7.

    Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.

    Ciaranello AL, Seage GR 3rd, Freedberg KA, Weinstein MC, Lockman S, Walensky RP.

    AIDS. 2008 Nov 12;22(17):2359-69.PMID: 18981776 [PubMed - indexed for MEDLINE]Related articles

    8.

    Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.

    Han J, Wang L, Jiang Y, Zhang Q, Fang L, Yao J, Wang Q.

    Int J STD AIDS. 2009 Apr;20(4):249-54.PMID: 19304969 [PubMed - indexed for MEDLINE]Related articles

    9.

    Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1.

    Wind-Rotolo M, Durand C, Cranmer L, Reid A, Martinson N, Doherty M, Jilek BL, Kagaayi J, Kizza A, Pillay V, Laeyendecker O, Reynolds SJ, Eshleman SH, Lau B, Ray SC, Siliciano JD, Quinn TC, Siliciano RF.

    J Infect Dis. 2009 May 1;199(9):1301-9.PMID: 19338474 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers.

    Mandala J, Torpey K, Kasonde P, Kabaso M, Dirks R, Suzuki C, Thompson C, Sangiwa G, Mukadi YD.

    BMC Public Health. 2009 Aug 27;9:314.PMID: 19712454 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Determinants of nonadherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Rwanda.

    Delvaux T, Elul B, Ndagije F, Munyana E, Roberfroid D, Asiimwe A.

    J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):223-30.PMID: 19131884 [PubMed - indexed for MEDLINE]Related articles

    12.

    Emergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child.

    Machado ES, Afonso AO, Nissley DV, Lemey P, Cunha SM, Oliveira RH, Soares MA.

    PLoS One. 2009;4(3):e4806. Epub 2009 Mar 11.PMID: 19277127 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.

    Mmiro FA, Aizire J, Mwatha AK, Eshleman SH, Donnell D, Fowler MG, Nakabiito C, Musoke PM, Jackson JB, Guay LA.

    J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):32-9.PMID: 19617849 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: a cohort study.

    Walter J, Kuhn L, Kankasa C, Semrau K, Sinkala M, Thea DM, Aldrovandi GM.

    BMC Infect Dis. 2008 Dec 30;8:172.PMID: 19116004 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Resistance to antiretrovirals in HIV-infected pregnant women.

    Weinberg A, Forster-Harwood J, McFarland EJ, Pappas J, Davies JK, Kinzie K, Barr EA, Paul SM, Salbenblatt CR, Soda E, Vazquez A, Levin MJ.

    J Clin Virol. 2009 May;45(1):39-42. Epub 2009 Mar 28.PMID: 19329355 [PubMed - indexed for MEDLINE]Related articles

    16.

    Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.

    Martinson NA, Morris L, Johnson J, Gray GE, Pillay V, Ledwaba J, Dhlamini P, Cohen S, Puren A, Steyn J, Heneine W, McIntyre JA.

    AIDS. 2009 Apr 27;23(7):809-16.PMID: 19287298 [PubMed - indexed for MEDLINE]Related articles

    17.

    In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.

    Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C, Bakaki P, Matovu F, Thigpen MC, Guay LA, McConnell M, Fowler MG, Jackson JB, Eshleman SH.

    AIDS Res Hum Retroviruses. 2009 Jul;25(7):673-7.PMID: 19552593 [PubMed - indexed for MEDLINE]Related articles

    18.

    Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

    Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R, Buard V, Kfutwah A, Vessière A, Rousset D, Teck R, Calmy A, Ciaffi L, Lazzarin A, Gianotti N.

    Antivir Ther. 2009;14(3):339-47.PMID: 19474468 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.

    Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Swai A, Lipyoga R, Mhalu F, Biberfeld G; Mitra Plus Study Team.

    J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):406-16.PMID: 19730269 [PubMed - indexed for MEDLINE]Related articles

    20.

    Interventions for preventing late postnatal mother-to-child transmission of HIV.

    Horvath T, Madi BC, Iuppa IM, Kennedy GE, Rutherford G, Read JS.

    Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006734. Review.PMID: 19160297 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk